Int. J. Mol. Sci. 2014, 15, 2431-2453; doi:10.3390/ijms15022431
                                                                                         OPEN ACCESS
                                                                             International Journal                                                                           Molecular Sciences
                                                                                     ISSN 1422-0067
                                                                            www.mdpi.com/journal/ijms
Article

PhosphoTyrosyl Phosphatase Activator Plasmodium falciparum: Identification Residues Involved Binding Activation PP2A
Audrey Vandomme 1, Aline Fréville 1, Katia Cailliau 2, Hadidjatou Kalamou 1,
Jean-François Bodart 2, Jamal Khalife 1,* Christine Pierrot 1,*
1
    Center Infection Immunity Lille, Inserm U1019-CNRS UMR 8204,
    University Lille Nord France, Institut Pasteur Lille, 1 Rue du Professeur Calmette,
    Lille 59019, Cedex, France; E-Mails: audrey.vandomme@pasteur-lille.fr  V.);
    alinekatia.freville@gmail.com  F.); hkalamou@gmail.com (H.K.)
2
    EA4479, IFR147, Laboratoire Régulation des Signaux Division, SN3,
    Université des Sciences et Technologies Lille, Villeneuve d’Ascq 59655, France;
    E-Mails: katia.maggio@univ-lille1.fr (K.C.); Jean-Francois.Bodart@univ-lille1.fr (J.-F.B.)

* Authors correspondence addressed; E-Mails: jamal.khalife@pasteur-lille.fr (J.K.);
  christine.pierrot@pasteur-lille.fr (C.P.); Tel.: +33-3-2087-7968 (J.K. & C.P.);
  Fax: +33-3-2087-7888 (J.K. & C.P.).

Received: 4 December 2013; revised form: 10 January 2014 / Accepted: 22 January 2014 /
Published: 11 February 2014


      Abstract: Plasmodium falciparum (Pf), causative agent deadliest form       malaria, tight regulation phosphatase activity crucial development       parasite. study, identified characterized PfPTPA homologous       PhosphoTyrosyl Phosphatase Activator, activator protein phosphatase 2A       major phosphatase involved biological processes eukaryotic cells. PfPTPA
      sequence analysis revealed amino acids involved interaction       PP2A human conserved P. falciparum. Localization studies showed PfPTPA
      PfPP2A present compartment blood stage parasites, suggesting       possible interaction proteins. vitro binding functional studies revealed
      PfPTPA binds activates PP2A. Mutation studies showed residues
      (V283, G292 M296) PfPTPA indispensable interaction G292
      residue essential activity. P. falciparum, genetic studies suggested       essentiality PfPTPA completion intraerythrocytic parasite lifecycle. Using
      Xenopus oocytes, showed PfPTPA blocked G2/M transition. Taken 
Int. J. Mol. Sci. 2014, 15                                                                          2432

      data suggest PfPTPA play role regulation P. falciparum cell
      cycle PfPP2A regulatory activity.

      Keywords: Plasmodium; PTPA; PP2A; phosphatase; dephosphorylation



1. Introduction

    processes eukaryotic cells control protein-protein interactions, notably case enzymes regulated post translational modifications protein interacting partners direct control activities. Protein phosphatases group enzymes counterbalance action kinases modulate proteins functions modifications phosphorylation status. Unlike kinases, phosphatases belong distinct protein/gene
families number, putatively experimentally identified different organisms, fewer kinases [1,2]. difference, fact phosphatases dephosphorylate diverse
substrates vitro, raised question specificity phosphatases regulation. Based observations accumulated past decade, mainly major
serine/threonine phosphatases PP1 PP2A, clear-cut evidence localization,
substrate specificity magnitude activity accomplished capacity catalytic subunit interact diverse regulatory proteins. PP1, 200 interacting proteins identified using variety biochemical, functional genetic approaches 129 proteins characterized [3–5]. contrast, seven regulators described PP2A [6–11]
including I2PP2A PhosphoTyrosyl Phosphatase Activator (PTPA) best characterized
regulators. phosphatases, observed regulators essential catalytic subunit itself. case PP2A, converging studies demonstrated involvement PTPA, known PP2A activator protein, activation loop PP2A cell growth survival [12–16]. PTPA purified rabbit skeletal muscle Xenopus laevis oocytes, specific capacity activate PP2A vitro [6]. activation shown ATP- Mg2+-dependent [6]. Subsequently PTPA cloned species sequence alignment
revealed high degree identity (>85 ) [17,18]. recently, PTPA described exhibit peptidyl prolyl isomerase activity (PPIase) [19] target proline 190 (P190) PP2A conserved PP2A. novel activity associated ability PTPA activate PP2A requires presence ATP-Mg2+ mutant PTPA abolished
PP2A activating function did PPIase activity. addition, mutated version PP2A
(P190A) shown partially active insensitive activation PTPA [19],
indicating proline essential activation process place.
    crystal structures human PTPA (HuPTPA) yeast orthologs determined [20–22]. structures showed PTPA overall α-helical structure identified highly conserved
cleft potential region interaction. basis HuPTPA structure, interaction PP2A different PTPA mutants investigated GST-pull revealed residues 18
(V209, E270, V281, G290, M294 K302) strongly contributed binding PP2A [20]. diverse biochemical functions PTPA PP2A detected vitro remain better defined Int. J. Mol. Sci. 2014, 15                                                                          2433
 global cellular spatiotemporal constraints, vivo studies revealed disruption lethal yeast controlling progression G1 phase cell cycle [15] G2/M transition [13].
   Plasmodium falciparum, virulent deadly parasite humans, number phosphatases characterized, including PP1 PP2A [23–39]. Despite importance enzymes direct implication cell cycle shown eukaryotic cells Plasmodium, experimental approaches carried identify regulators.
Recently, characterized regulators PfPP1, named PfLRR1 [40], Inhibitor 2 (PfI2) [41] Inhibitor 3 (PfI3) [42]. PfLRR1 PfI2, expected, showed strong capacity inhibit PfPP1 activity exhibit substantial differences binding motifs PP1.
Unexpectedly, PfI3, unlike human counterpart clearly revealed activation PP1 lack complement Inhibitor 3 deficient yeast [42]. Additionally, reverse genetic studies suggested regulators essential blood parasite growth. Finally, peptides derived PfI2 PfI3 competing main binding site PP1 exhibited anti-plasmodial activity blood stage parasites vitro [41,42].
   respect PP2A, biochemical chromatography approaches combined micro-sequencing procedure suggested presence PP2A-like catalytic subunit parasite [26]. Subsequently, availability P. falciparum genome, transcriptomic proteomic studies confirmed expression different parasite stages. regulator PfPP2A characterized Dobson et al. [43]. authors reported expression P. falciparum homolog Inhibitor 2 PP2A (PfI2PP2A), based fact primary
structure PfI2PP2A exhibited overall identity 28  55  similarity human
counterpart, PfI2PP2A specifically inhibited PP2A overexpression HeLa cells led increase phosphorylation transcription factors. protein essential asexual
erythrocytic cycle Plasmodium berghei (rodent Plasmodium specie).  Leiden Malaria
Research Group Istituto Superiore di Sanita failed disrupt PbI2PP2A gene double
crossing (http://www.pberghei.eu/index.php?rmgm=246) despite accessibility locus PbI2PP2A-GFP tagging integration (http://www.pberghei.eu/index.php?rmgm=218). exact
physiological function PfI2PP2A examined, location cytoplasm P. falciparum
strongly suggests regulatory function place compartment. regulators PfPP2A characterized far.
   present study, report characterization PfPTPA, P. falciparum homolog human PhosphoTyrosyl Phosphatase Activator protein able directly bind PP2A. vitro binding studies recombinant wild type mutated proteins showed residues (V283, G292 M296) PfPTPA important interaction. Functional studies
revealed PfPTPA activates PP2A vitro residues (E272, V283, G292, M296 K304) involved dramatic loss function mutated PfPTPA G292A protein. P. falciparum,
genetic studies suggested essentiality PfPTPA completion intraerythrocytic
parasite life cycle. studies, using heterologous model, showed PfPTPA interacted endogenous PP2A microinjection PfPTPA Xenopus oocytes blocked G2/M transition.
Int. J. Mol. Sci. 2014, 15                                                                        2434

2. Results Discussion

2.1. Molecular Cloning Sequence Analysis PfPTPA

   P. falciparum genome encodes single putative PTPA (PF3D7_1430100, 319 amino acids,
37.4 kDa). predicted gene contained 5 exons cloned identified
experimentally. isolated RT-PCR product P. falciparum blood stage total RNA using
primers spanning length sequence. complete sequencing independent clones
showed open reading frame 960 bp (Supplementary Figure S1), confirming ORF annotated PlasmoDB [44] (www.plasmodb.org). Reciprocal BLASTP analysis using deduced amino acid
sequence query confirmed homology gene product known PTPA. comparison human counterpart revealed overall identity 32  (54  homology), reaching maximum 40  C-terminal region sequence (Figure 1a). PfPTPA orthologs present sequenced rodent human Plasmodium species. ClustalW program used generate alignment Plasmodium PTPA sequences species including
human Toxoplasma gondii sequences. outgroups, inhibitors PP1 PP2A included. resulting alignment used generate maximum likelihood phylogenetic tree. data
presented Figure 1b clearly shows Plasmodium PTPAs form divergent subgroup T. gondii cluster group known PTPAs, confirming relatedness PfPTPA PhosphoTyrosyl Phosphatase Activator family (Figure 1b).
   human PTPA, noted analysis crystal structure combined amino acid mutation studies revealed amino acids present C-terminal region protein (V209, E270, V281, G290, M294 K302) critical function PP2A [20]. P. falciparum amino acids conserved PfPTPA correspond E272, V283, G292, M296 K304 positions (Figure 1a). shed light position conserved residues global structure PfPTPA, 3D model built using human PTPA
(PDB: 2IXM) template (https://modbase.compbio.ucsf.edu/scgi/modweb.cgi) (Figure 1c,d).
   overall structure showed differences human P. falciparum homologs.  human PTPA composed thirteen α helices β sheets PfPTPA composed sixteen α helices β sheet. α helices localized identically proteins helices HuPTPA subdivided shorter helices PfPTPA
(Supplemental Figure S2). model shows residues involved PP2A interaction human identical structures residues G292 K304 α helix structure human P. falciparum. Despite differences, crystal human PTPA PfPTPA model
showed residues periphery shown Figure 1c,d. similarity suggests residues involved binding domain PP2A conserved human P. falciparum PTPA.
Int. J. Mol. Sci. 2014, 15                                                                          2435

      Figure 1. Molecular cloning sequence analysis PfPTPA.   Analysis PfPTPA
      (PF3D7_1430100) amino acid sequence. PfPTPA aligned human PTPA
      (CAA60163.1) using ClustalW Multiple Alignment (BioEdit). identical residues       highlighted black similar residues grey. Stars symbolized amino acids involved       PTPA/PP2A interaction human; (b) Phylogenic tree PTPA family. maximum
      likelihood tree generated 21 PTPA sequences using MEGA5 [45]       JTT + G + model 100 bootstrap repetitions. Outgroups formed PP2A inhibitor
      2 orthologs (I2PP2A, outgroup 1) PP1 inhibitor 2 orthologs (I2PP1, outgroup 2) PP1
      inhibitor 3 orthologs (I3PP1, outgroup 3); (c) Crystal structure HuPTPA (PDB: 2IXM).
      Amino acid residues involved PTPA/PP2A interaction shown red; (d) Structural
      model PfPTPA based crystal structure HuPTPA (PDB: 2IXM) using       ModBase server [46]. Amino acid residues studied work PTPA/PP2A
      interaction shown red.
Int. J. Mol. Sci. 2014, 15                                                                         2436

                                            Figure 1. Cont.




2.2. Expression PfPTPA PfPP2A Plasmodium falciparum Localization

   RNA-Seq data available PlasmoDB [44] showed gene transcribed blood
stage parasites, peak late trophozoites (32 h). PfPTPA transcripts identified gametocytes protein detected proteomics asexual sexual parasites
examined [47–49]. PTPA activator PP2A [6,20,50], plotted RNA-Seq data obtained PfPTPA. Results depicted Figure 2a showed transcripts detectable early stage trophozoites higher level PP2A transcripts
(24 h post infection). late trophozoites/schizonts (32–40 h post infection), relative abundance transcripts similar, suggesting PfPP2A activated PfPTPA late developmental stages intraerythrocytic lifecycle.
   Based observations, sought follow distribution PfPTPA PfPP2A intraerythrocytic development cycle. end, P. falciparum 3D7 strain transfected pARL2 constructs mediating episomal expression pfptpa pfpp2a-gfp length sequences (Figure 2b). use vector Kuhn et al. showed trafficking dependent fused protein pfcrt promoter used [51]. Using monoclonal
anti-GFP antibody, immunoblot analysis total extract blood stage parasites expressing PfPTPA-GFP PP2A-GFP revealed presence specific bands expected size fused protein (Figure 2c, lanes 2 3), demonstrating integrity fused protein transfected parasites.
   Examination live parasites transfected pfptpa-gfp showed signal confined parasite distribution nucleo-cytoplasmic rings, trophozoites schizonts
(Figure 2d), fluorescence partially overlapped DNA staining. Parasites transfected construct containing pfpp2a-gfp showed nucleo-cytoplasmic distribution rings schizonts intense accumulation nucleus late trophozoites (Figure 2e). results accordance previous localization studies mammalian cells showing PTPA PP2A Int. J. Mol. Sci. 2014, 15                                                                         2437

nucleo-cytoplasmic localization accumulation nucleus human cells progressed S phase [52], Fission Yeast [12] respectively. PfPTPA-GFP PfPP2A-GFP signal completely absent digestive food vacuole cytoplasm red blood cells (Figure 2d,e). presence PfPP2A PfPTPA cytoplasm nuclear compartments parasite
suggests potential interaction proteins raises question potential regulatory
effect PP2A activity.

      Figure 2. Expression pfptpa pfpp2a gene Plasmodium falciparum       localization   Representation pfptpa (black bars) pfpp2a (grey bars) RNA
      expression erythrocytic life cycle P. falciparum. Data plotted       PlasmoDB [44]; (b) Schematic representation pARL2-pfptpa-gfp       pARL2-pfpp2a-gfp vectors used episomal expression PfPTPA PfPP2A;
      (c) expression proteins checked western blotting anti-GFP
      antibodies separation 15  SDS-PAGE. Lane 1 represents extract wild type
      parasites. Lane 2 3 represent extracts PfPTPA PfPP2A transfected parasites
      respectively. Expression localization PfPTPA-GFP (d) PfPP2A-GFP (e)
      erythrocytic cell cycle P. falciparum analyzed fluorescence
      microscopy transfection described experimental section.
Int. J. Mol. Sci. 2014, 15                                                                         2438

2.3. Binding PfPTPA PP2A

    interaction PfPTPA PfPP2A investigated. production proteins E. coli revealed PfPTPA produced soluble non-denaturing conditions, PfPP2A obtained active form did activity pNPP, canonical substrate phosphatases. order overcome point, used Xenopus oocytes previously reported able produce Plasmodium proteins [40].  injected oocytes recombinant tagged-PfPTPA protein cRNA corresponding Myc tagged-PfPP2A
protein. Oocyte lysates prepared mentioned Experimental section used immunoprecipitation/western blot experiments. shown Figure 3a, immunoblot analysis PfPTPA immunoprecipitates using anti-tag antibodies showed PfPP2A immunoprecipitated PfPTPA. ascertain direct interaction PfPTPA PP2A, fact PP2A highly conserved different species, human PP2A
commercially available used binding ELISA based assay. Results presented Figure 3b
evidenced capacity PfPTPA bind coated HuPP2A intensity signal dependent PfPP2A added. Taken  data demonstrate PfPTPA
physically interacts PfPP2A support previous results showing direct interaction PTPA PP2A [53].
   fact PTPA conserved species suggests use conserved set amino acids interact PP2A. Based sequence comparison depicted Figure 1a, residues involved human PTPA/PP2A interaction conserved Plasmodium. explore role conserved residues PfPTPA binding PfPP2A, PfPTPA versions
containing single mutation critical amino acid residue produced recombinant proteins used immunoprecipitation assays. control, PfPTPA protein containing mutations (PfPTPA 5mut) produced tested conditions. immunoprecipitation assays performed lysates oocytes injected wild mutant tagged-PfPTPA proteins (PfPTPA E272A, PfPTPA V283A, PfPTPA G292A, PfPTPA M296A PfPTPA K304A) cRNA translating Myc tagged-PfPP2A. Results showed binding mutants E272A K304A impaired binding mutants V283A, G292A M296 abolished (Figure 3c). results suggest differential binding domain human Plasmodium.  HuPTPA E270 residue essential interaction residues
G290 M294 residues V281 K302 important. Finally, major difference human Plasmodium binding PTPA PP2A concerns E270 residue (corresponding E272 P. falciparum) critical human Plasmodium. difference suggests differential binding domain related difference tertiary structure PTPA organisms. notable version PfPTPA protein containing mutations did interact PfPP2A. Taken  data confirm V283, G292 M296 residues PfPTPA involved interaction PfPP2A.
Int. J. Mol. Sci. 2014, 15                                                                      2439

      Figure 3. Interaction studies PfPTPA PP2A.   Binding PfPTPA PfPP2A       Xenopus oocyte. immunoprecipitation PfPTPA-PfPP2A complex anti       antibodies (recognizing recombinant PfPTPA tagged 6  (lanes 2 3)       microinjected Xenopus extracts. anti-mouse IgG antibody (lane 1) used       control. Immunoprecipitates Xenopus oocytes microinjected water (−)       PfPTPA (+) eluted separated SDS-PAGE transferred nitrocellulose
      membrane. Immunoblot analysis performed anti antibodies (recognizing
      PfPTPA) (upper panel) anti-Myc antibodies (recognizing PfPP2A) (lower panel);
      (b) Interaction PfPTPA HuPP2A vitro assessed ELISA based assay.
      Increasing quantities biotinylated recombinant PfPTPA added wells coated
      human PP2A (100 ng  BSA (100 ng  negative control. Results       means ± SEM independent experiments performed duplicate (stars (*) represent
      significant differences p = 0.01); (c) Binding mutated PfPTPA PfPP2A       Xenopus oocytes. immunoprecipitation experiment PfPTPA-PfPP2A complexes
      anti antibodies (recognizing recombinant wild type mutated PfPTPA)
      (upper panel) anti-Myc antibodies (recognizing PfPP2A) (lower panel)       microinjected Xenopus oocytes. Immunoprecipitates Xenopus oocytes microinjected
      water, WT mutated PfPTPA eluted separated SDS-PAGE       transferred nitrocellulose membrane. Immunoblot analysis performed anti       anti-Myc antibodies.




2.4. Effect PfPTPA Activity PP2A

   previously reported PTPA proteins able regulate PP2A increasing activity different substrates including, limited  pNPP substrate [6]. assays produce recombinant active PfPP2A unsuccessful, PfPTPA able bind
HuPP2A (Figure 3b), function PfPTPA activity HuPP2A assessed. Using Int. J. Mol. Sci. 2014, 15                                                                         2440

concentration human PP2A range producing linear release phosphate, effect wild-type mutated recombinant PfPTPA proteins evaluated described Experimental
section. Results showed significant increase phosphatase activity  200 ) PP2A preincubated PfPTPA wild type (Figure 4). PfPTPA mutated proteins tested 10 nM, observed mutations led complete loss function PfPTPA
(Figure 4). higher contentration (100 nM), PfPTPA G292A protein unable activate PP2A, mutated proteins showed slight increase PP2A activity. PfPTPA protein containing mutations inactive concentration used. data, immunoprecipitation experiments suggest G292 vital primary
residue activity PfPTPA. important remember human PTPA residues K302 equally essential activity [20]. fact PfPTPA exhibits residues  key role G292, suggest particular interaction PfPTPA PfPP2A adequately adapt activation enzyme specific substrate Plasmodium.

      Figure 4. Effect wild type mutated PfPTPA proteins PP2A activity. capacity
      PfPTPA (WT mutated) regulate HuPP2A assessed using pNPP activity tests.
      human PP2A activity measured 405 nm release p-nitrophenol       incubation different concentration recombinant WT mutated PfPTPA proteins.
      Results presented fold change human PP2A activity means ± SEM       independent experiments (stars (*) represent significativity p = 0.01).




2.5. Genetic Manipulations pfptpa pfpp2a Plasmodium falciparum

   previously shown disruption pp2a ptpa ortholog genes yeast results lethality [14,54]. mice, reported homozygous null PP2A detected embryonic stage viable [55]. study lack PfPTPA PfPP2A expression affect Plasmodium blood stage life cycle, attempted disrupt genes single
crossing homologous recombination using pCAM vector (Figure 5a,b). transfected
blood ring stage parasites 3D7 strain pCAM-BSD-pfptpa pCAM-BSD-pfpp2a
constructs containing 5' fragments derived respective genomic sequences bsd gene
conferring resistance blasticidin (Figure 5a,b). transfections drug treatments, presence construct checked plasmid rescue approach previously described (data shown). integration viable parasites analyzed PCR genomic DNA, using
oligonucleotides presented Supplemental Table S1. Template DNA wild parasites used Int. J. Mol. Sci. 2014, 15                                                                          2441

control. amplicons corresponding wild locus amplicons diagnostic PfPTPA PfPP2A detectable transfected parasites (Figure 5c lanes 1 3, Figure 5d
lanes 1 3). generation mutant parasites demonstrates accessibility locus. order examine phenotype mutant parasites, attempted establish stable clonal lines limiting dilution. Unexpectedly, unable obtain viable clones did express pfptpa pfpp2a genes. confirmed fact cloned parasites expressed PfPTPA PfPP2A detected RT-PCR  shown). suggests initial genomic integration transitory genes fact essential stage completion intraerythrocytic cycle. results related PfPP2A supported previous studies reporting okadaic acid, inhibitor phosphatase activities, able drastically block blood parasite growth vitro, suggesting essentiality phosphatases including PfPP2A [56]. studies required examine essential functions precise timing proteins critical parasite growth/development. await development powerful robust inducible expression Plasmodium falciparum proteins. complementary approach study function genes use inducible rodent Plasmodium T. gondii.

      Figure 5. Genetic studies pfptpa pfpp2a.  b) Gene-targeting construct       gene disruption single homologous recombination using pCAM-BSD,       locus resulting integration knockout pfptpa   pfpp2a (b) construct.
      (c,d) Analysis pCAM-BSD-pfptpa (c) pCAM-BSD-pfpp2a (d) transfected 3D7
      culture PCR; lanes 1–3 correspond DNA extracted transfected parasites;
      lanes 4–6 correspond DNA extracted wild type parasites. Lanes 1 4 represent
      detection length wild type locus (PCR p9-p8 p31-p30 respectively);
      lanes 2 5 represent detection episomal DNA (PCR p10 p11);       lanes 3 6 represent detection integration insert (PCR p9-p11       p31-p11 respectively).
Int. J. Mol. Sci. 2014, 15                                                                       2442

      Figure 6. Inhibition G2/M transition Xenopus oocytes PfPTPA.   Percentage       GVBD induced progesterone (PG), PfPTPA microinjection PfPTPA
      followed PG incubation; (b) Percentage GVBD induced PG incubation       microinjection different PfPTPA; (c) Binding PfPTPA XePP2A       Xenopus oocytes. immunoprecipitation experiment PfPTPA-XePP2A complex
      anti antibodies (recognizing recombinant PfPTPA tagged 6  (lanes 2
      3) microinjected Xenopus oocytes. anti-mouse IgG antibody (lanes 1)       used control. Immunoprecipitates Xenopus oocytes microinjected water (−)
      PfPTPA (+) eluted, separated SDS-PAGE transferred nitrocellulose
      membrane. Immunoblot analysis performed anti antibodies (recognizing
      PfPTPA) (upper panel) anti-XePP2A antibodies (lower panel); (d) Effect PfPTPA       progesterone-dependent GVBD Xenopus oocytes. Percentage GVBD induced PG
      microinjection 10 ng PfPTPA WT mutated (n = 2).




2.6. Inhibition G2/M Transition Xenopus oocytes PfPTPA

   PP2A major Ser/Thr phosphatases dephosphorylate diverse proteins involved control eukaryotic cell cycle [57–59]. context Xenopus oocytes, inhibition PP2A
promotes G2/M transition enabling activation M-Phase Promoting Factor, universal
factor M-Phase entry.  activity PP2A contributes block oocytes G2-like state antagonizing MPF activation [60]. G2/M transition Xenopus oocytes triggered vitro hormonal stimulation addition progesterone medium [61], provoking oocyte
Germinal Vesicle Breakdown GVBD. PfPTPA activates PP2A, preinjection oocytes lead inhibition progesterone-induced maturation. rationale mind, assessed Int. J. Mol. Sci. 2014, 15                                                                       2443

impact PfPTPA G2/M transition induced progesterone.  important emphasize microinjection PfPTPA did produce GVBD (Figure 6a),  expected progesterone induced GVBD (Figure 6a). Results presented Figure 6a showed PfPTPA able block GVBD induced progesterone. threshold inhibition started observed 10 ng/oocyte (Figure 6b). parallel, important verify PfPTPA bind
Xenopus PP2A (XePP2A). shown Figure 6c, use specific PP2A antibodies immunoblot
analysis eluates immunoprecipitated anti antibodies revealed presence XePP2A complex early 15 mn post injection. complex detectable 2 18 h
post-injection, PfPTPA present oocyte extracts, suggesting early detection rapid action PfPTPA. model, propose PfPTPA activate PP2A consequently
dephosphorylates key substrate required signal pathway activated progesterone.
    used approach evaluate contribution activity amino acid residues
involved PP2A binding. Results showed mutations V283A, G292A M296A completely
abrogated function PfPTPA GVBD observed progesterone treatment
(Figure 6d). notable immunoprecipitation experiments showed mutated
proteins exhibited strong decrease binding capacity XePP2A (Supplemental Figure S4).
Concerning E272A K304A mutated proteins, loss function detectable. Altogether, data confirmed role residue G292 showed residues V283 M296 participate function PfPTPA.  residues E272 K304 did affect binding function PfPTPA.

3. Experimental Section

3.1. Materials

    Plasmid pETDuet-1 purchased Novagen. Plasmids pCAM-BSD pCAM-BSD-HA kind gift C. Doerig (Monash University, Melbourne, Australia) plasmid pARL kind
gift C. Sanchez (Heidelberg, Germany). Protein phosphatase 2A C subunit (human recombinant) purchased Cayman Chemical (Ann Arbor, MI 48108, USA). Monoclonal antibodies
anti-PP2A alpha, anti-GFP, anti-penta horseradish peroxidase-labeled anti-mouse IgG purchased Abcam (Cambridge, UK), Roche (Basel, Switzerland), Qiagen (Venlo, Netherlands) Santa Cruz Biotechnology (Santa Cruz, CA, USA) respectively.

3.2. Phylogenetic Analyses Secondary Structure Prediction

   Protein sequences (listed Supplemental Table S2) aligned using ClustalW algorithm
implemented BioEdit v7.1 software (Ibis Biosciences, Carlsbad, CA, USA), manually
corrected. Maximum likelihood trees built using MEGA5 [45] JTT + + G model, 100 bootstrap repetitions following species: Plasmodium falciparum, Plasmodium berghei,
Plasmodium chabaudi, Plasmodium vivax, Plasmodium yoelii yoelii, Toxoplasma gondii, Arabidopsis
thaliana, Homo sapiens, Mus musculus, Trypanosoma brucei, Tetrahymena thermophila, Xenopus
laevis, Danio rerio, Saccharomyces cerevisiae, Theileria parva, Drosophila melanogaster, Leishmania
major, Oryza sativa, Caenorhabditis elegans Schistosoma mansoni.
Int. J. Mol. Sci. 2014, 15                                                                       2444

   PfPTPA secondary prediction carried using ModWeb server [46].

3.3. Preparation Parasites

   P. falciparum 3D7 clone grown according Trager et al. [62], RPMI-1640 medium
supplemented 0.5  AlbuMAXTMII (Invitrogen, Paisley, Scotland, UK), 0.2 mM Hypoxanthin
(CCPro, Oberdorla, Germany) 20 µg/mL Gentamycin (Invitrogen), presence O+
erythrocytes. Cultures maintained 37 °C humidified athmosphere (5  CO2). Parasites synchronized double sorbitol treatment previously described [63]. isolate total DNA protein, parasitized erythrocytes lysed saponine [64] pelleted. Soluble protein extracts prepared resuspending parasite pellet lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl,
1  Triton X-100 EDTA-free protease inhibitor cocktail (Roche, Boulogne Billancourt, France) hour wheel 4 °C followed sonication step. Total DNA extracted using KAPA
Express Extract kit (KAPABioSystem, Montrouge, France) according manufacturer’s protocol.
Genomic DNA (gDNA) resuspended parasite pellet lysis buffer (50 mM Tris-HCl pH 7.5,
150 µg/mL proteinase K 2  SDS) 2 h 55 °C followed extraction steps phenol-chloroform (addition 1 volume). gDNA precipitated 1/10th volume sodium
acetate 2 volumes Ethanol 100 . gDNA washed twice resuspended H2O.

3.4. Localization PfPTPA PfPP2A

   primers used study listed Supplemental Table S1. episomal
expression PfPTPA-GFP PfPP2A-GFP, length coding region pfptpa (Pf3D7_1430100) pfpp2a (Pf3D7_0314400) amplified strand cDNA PCR using primers p3-p4 p25-p26 respectively containing XhoI KpnI restriction sites. PCR fragments cloned PCR2.1-TOPO vector (Invitrogen, San Diego, CA, USA) nucleotide sequences verified sequencing (Eurofins, Ebersberg, Germany). PCR products subcloned frame GFP pARL vector [51] digested XhoI KpnI. plasmid carries human dhfr gene selection WR99210 pfcrt promoter. Ring stages 3D7 parasites transfected 100 µg plasmid DNA electroporation, according Sidhu et al. [65]. populations stably
transfected parasites obtained weeks. Live parasites analyzed images recorded fluorescence microscopy (LSM710, Zeiss, Marly le Roi, France).

3.5. Generation P. falciparum Transgenic Parasites

   disruption pfptpa pfpp2a performed insertion PCR product
corresponding 5' portion PfPTPA (765 bp) PfPP2A (800 bp) sequences pCAM-BSD vector contains cassette conferring resistance blasticidin. insert obtained
using 3D7 genomic DNA template oligonucleotides p5-p6 p27-p28 contain PstI BamHI restriction sites respectively.
   P. falciparum parasites (ring stages) transfected described  48 h transfection, order select transformed parasites, blasticidin (Invivogen, San Diego, CA, USA) added Int. J. Mol. Sci. 2014, 15                                                                           2445

final concentration 2.5 µg/mL. Resistant parasites appeared weeks maintained drug selection. Populations stably transfected parasites obtained weeks.

3.6. Genotype Phenotype Analysis P. falciparum Transfectants

   Genotype pfptpa pfpp2a knock parasites analyzed PCR genomic DNA using primers p9 p31 respectively (derived 5' non-translated region absent construct) p11 specific pCAM-BSD vector.
   order study phenotype knock parasites, cloning limiting dilution performed.
Limiting dilutions set 96 plates 3  hematocrit RPMI-1640 medium
supplemented 0.5  AlbuMAXTMII, 0.2 mM Hypoxanthin, 20 µg/mL Gentamycin 2.5 µg/mL blasticidin. contained 200 µL medium average 0.1–0.5 parasite.
Medium changed day intervals beginning day seven. day 21, smears performed select positive wells. positive wells selected amplified. Cloning verified PCR genomic extracted DNA primers p9-p8 pfptpa p31-p30 pfpp2a.

3.7. Recombinant Proteins Expression Purification

   order obtain coding region PfPTPA, primers p1 p2 (Supplemental Table S1) designed according sequence putative PfPTPA (Pf3D7_1430100) available Plasmodium
Data Base (PlasmoDB) (http://plasmodb.org/plasmo/). PCR performed strand cDNA unsynchronized blood cultures P. falciparum 3D7 p1 p2 primers using Advantage 2
PCR kit (Clontech, St. Germain Layes, France). PCR products cloned PCR 2.1-TOPO
vector (Invitrogen) sequenced. Comparative analyses performed BIOEDIT software ClustalW algorithm. sequence analysis, coding region PfPTPA subcloned pETDuet-1 allows expression protein fused histidines tag.
   purpose produce recombinant PfPP2A protein, PCR performed strand
cDNA unsynchronized blood cultures P. falciparum 3D7 p23 p24 primers. PCR
products sequenced subcloned pETDuet-1 
   obtain PfPTPA mutant constructs, carried PCR-based site-directed mutagenesis
strategy using ISIS Proofreading DNA Polymerase. pETDuet-PfPTPA used template primers p13-p14 (PfPTPA E272A), p15-p16 (PfPTPA V283A), p17-p18 (PfPTPA G292A), p19-p20
(PfPTPA M296A) p21-p22 (PfPTPA K304A). PCR conditions consisted 1 min 95 °C
followed 16 cycles 95 °C (30 s), 50 °C (1 min) 72 °C (9 min). parental DNA plasmid digested DpnI aliquot used transform XL10-Gold Ultracompetent cells
(Stratagene, Amsterdam Zuidoost, Netherlands). Mutated plasmids checked sequencing used expression mutated PfPTPA recombinant proteins. pfptpa-5mut gene
containing mutations optimized codons synthetized (Genscript, Piscataway, NJ,
USA) (Sequence presented Supplemental Figure S3). order express PfPTPA-5mut recombinant
protein, synthetic gene subcloned pETDuet vector.
   Expression PfPTPA-6His mutated PfPTPA-6His carried E. coli BL21 strain presence 0.5 mM IPTG 16 °C overnight. Proteins extracted lysis buffer (20 mM
Tris-HCl pH 7.4, 150 mM NaCl, 1  Triton X-100, lysozyme 1 mg/mL Protease inhibitor Cocktail
Int. J. Mol. Sci. 2014, 15                                                                      2446

(Roche)) 1 h 4 °C wheel followed sonication step. extract loaded 1 mL
nickel Ni-NTA column (Protino NiNTA, Macherey Nagel, Düren, Germany). Washing steps carried buffer containing 20 mM Tris-HCl pH 7.4, 150 mM NaCl 20 mM Imidazole.
Proteins eluted Imidazole gradient dialyzed 20 mM Tris-HCl pH 7.4, 150 mM NaCl. conditions, purity checked SDS-PAGE followed SimplyBlue™ safe staining
(Invitrogen, San Diego, CA, USA) >90 .
   attempts produce PfPP2A using pETDuet plasmid containing coding
region PfPP2A. Unfortunately, produce concentrated, soluble active
recombinant PfPP2A protein. Considering sequence homology PfPP2A mammalian
PP2A, activity interaction tests performed using Xenopus (endogene) Human PP2A
(Cayman, Tallinn, Estonia).

3.8. RNA Synthesis PfPP2A

   Capped mRNA (cRNA) synthetized using T7 mMessage mMachine kit (Ambion, Austin,
TX, USA). cRNA transcribed 1 µg PfPP2A-pGBKT7 linearized BamHI (Fermentas,
St. Leon-Rot, Germany). cRNA precipitated 2.5 M LiCl, washed 70  ethanol resuspended 20 µL diethyl pyrocarbonate-treated water quantified spectrophotometry. Finally 1 µg cRNA analyzed denaturing agarose gel. Gel staining 10 µg/mL ethidium bromide
allowed confirmation size PfPP2A cRNA absence abortive transcript.

3.9. Induction Xenopus Oocytes Germinal Vesicle Breakdown Immunoprecipitation

   Preparation Xenopus laevis oocytes microinjection experiments performed previously described [66]. approaches used.
   Briefly, assay, 20 oocytes removed animals pre-injected His6-PfPTPA (wild type mutated) recombinant proteins 1 h incubation 10 µM human progesterone (Sigma, St. Louis, MO, USA). Progesterone used positive control oocyte maturation. Preliminary experiments using different concentrations ranging 2 40 ng injection showed 10 ng PfPTPA sufficient inhibit dramatically progesterone induced
GVBD. GVBD detected appearance white spot apex animal pole 15 h.
   order carry immunoprecipitation, oocyte extracts 20 oocytes removed animals prepared 15 min microinjection PfPTPA (WT mutated) follows: oocytes lysed buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 0.05  SDS, 0.5 
Triton X100, 5 mM MgCl2, 1 mg/mL bovine serum albumin, 10 µg/mL leupeptin, 10 µg/mL aprotinin,
10 µg/mL soybean trypsin inhibitor, 10 µg/mL benzamidine, 1 mM PMSF, 1 mM sodium vanadate) centrifuged 4 °C 15 min 10,000g. detect His6-PfPTPA proteins, electrophoresis
followed western-blot analysis performed oocyte extracts. membranes developed anti-penta antibodies (Qiagen, Courtaboeuf, France).
   second approach used order test PfPTPA interaction PfPP2A. assay,
20 oocytes removed different animals pre-injected PfPP2A cRNA
18 h microinjection wild-type mutated PfPTPA proteins. control, PfPTPA
recombinant protein injected  Oocyte extracts prepared 15 min microinjection Int. J. Mol. Sci. 2014, 15                                                                        2447

detect interaction PfPP2A PfPTPA proteins. 180 µL oocyte lysate PY buffer [67] incubated 2 µL antibodies 3 h 4 °C rotation.  50 µL 50  solution
protein sepharose (Sigma, St. Louis, MO, USA) added 1 h. washes 15 min, beads resuspended 6 µL buffer electrophoresis followed western-blot
analysis performed. immunoprecipitations using anti antibodies (Qiagen,
Courtaboeuf, France), anti-Myc (Santa-Cruz Biotechnology, Heidelberg, Germany) anti-mouse
antibodies control. membranes revealed anti-Myc antibodies (Santa-Cruz
Biotechnology) anti antibodies (Qiagen) (dilution 1/1000). Antibodies complexes detected using Western blotting Luminol Reagent (sc-2048, Santa-Cruz Biotechnology).

3.10. Assays PP2A Effect PfPTPA

   Phosphatase assays carried buffer containing 40 mM Tris-HCl pH 8.4, 34 mM MgCl2,
4 mM EDTA, 2 mM DTT, 0.05 mg/mL Bovine serum albumin (BSA) 1 mM ATP 37 °C 30 min 20 mM para-NitroPhenyl Phosphate substrat (pNPP). Initial experiments performed determine optimal conditions human PP2A activity. reaction started adding
20 mM pNPP final volume 200 µL. incubation period 30 min 37 °C, liberated
para-Nitrophenol quantified measurement absorbance 405 nm. investigate role PfPTPA PP2A, 0.04 µg human PP2A preincubated different quantities ranging 0 0.4 µg recombinant WT mutated PfPTPA 30 min 37 °C testing PP2A
phosphatase activity.

3.11. Measurement Binding PfPTPA PP2A

   Binding PfPTPA human PP2A assessed ELISA-based assay. Plates coated 1 µg/mL human PP2A BSA PBS overnight 4 °C. Following washings PBS-Tween 20 0.1 , plates blocked PBS-gelatin 1  1 h room temperature. Coated
plates incubated different concentrations PfPTPA (WT mutated), previously
labeled biotin-N-hydroxysuccinimide according manufacturer’s instructions (Calbiochem,
Nottingham, UK). Incubation biotinylated-PfPTPA different proteins performed PBS-Tween 20 0.1  37 °C 2 h. Following washes  described , binding detected using streptavidin-horseradish peroxidase. incubation time 20 min washes, tetramethylbenzidine (TMB) (Uptima, Montluçon, France) added, reaction stopped using 2N HCl. optical density measured ELISA plate reader 450 nm.

4. Conclusions

    work, report characterization PfPTPA, homolog human
Phosphotyrosyl Phosphatase Activator, regulator PP2A. showed direct interaction PfPTPA PfPP2A assessed importance V283, G292 M296 residues interaction absence interacting site. expected, PfPTPA activates PP2A vitro critical contribution G292 residue activity. Using Xenopus oocyte model, observed microinjection PfPTPA blocked G2/M transition. PfPTPA essential Int. J. Mol. Sci. 2014, 15                                                                        2448

completion intraerythrocytic lifecycle parasite.  order elucidate exact
role PTPA parasite cell cycle, assays conditional KO Plasmodium berghei investigation. confirmation essential role PTPA, suggest consideration protein new lead drug design.

Acknowledgments

   thank Sophia Lafitte Caroline Witte technical assistance Mathieu Vanderstraete advice phylogenetic analysis. thank Alain Martoriati helpful discussions. work supported Inserm, CNRS University Lille Nord France.

Conflicts 
     authors declare conflict 

References

1.  Manning, G.; Whyte, D.B.; Martinez, R.; Hunter, T.; Sudarsanam, S. protein kinase
    complement human genome. Science 2002, 298, 1912–1934.
2. Sacco, F.; Perfetto, L.; Castagnoli, L.; Cesareni, G. human phosphatase interactome:     intricate family portrait. FEBS Lett. 2012, 586, 2732–2739.
3. Bollen, M.; Peti, W.; Ragusa, M.J.; Beullens, M. extended PP1 toolkit: Designed create
    specificity. Trends Biochem. Sci. 2010, 35, 450–458.
4. Fardilha, M.; Esteves, S.L.; Korrodi-Gregorio, L.; da Cruz e Silva, O ; da Cruz e Silva, F.F.     physiological relevance protein phosphatase 1 interacting proteins health disease.
    Curr. Med. Chem. 2010, 17, 3996–4017.
5. Hendrickx, ; Beullens, M.; Ceulemans, H.; Den Abt, T.; van Eynde, ; Nicolaescu, E.;
    Lesage, B.; Bollen, M. Docking motif-guided mapping interactome protein phosphatase-1.
    Chem. Biol. 2009, 16, 365–371.
6. Cayla, X.; Goris, J.; Hermann, J.; Hendrix, P.; Ozon, R.; Merlevede, W. Isolation     characterization tyrosyl phosphatase activator rabbit skeletal muscle Xenopus laevis
    oocytes. Biochemistry 1990, 29, 658–667.
7. Junttila, M.R.; Puustinen, P.; Niemela, M.; Ahola, R.; Arnold, H.; Bottzauw, T.; Ala-aho, R.;
    Nielsen, C.; Ivaska, J.; Taya, Y.; et al. CIP2A inhibits PP2A human malignancies. Cell 2007,
    130, 51–62.
8. Kong, M.; Ditsworth, D.; Lindsten, T.; Thompson, C.B. Alpha4 essential regulator PP2A
    phosphatase activity. Mol. Cell 2009, 36, 51–60.
9. Li, M.; Guo, H.; Damuni,  Purification characterization potent heat-stable protein
    inhibitors protein phosphatase 2A bovine kidney. Biochemistry 1995, 34, 1988–1996.
10. Mochida, S.; Maslen, S.L.; Skehel, M.; Hunt, T. Greatwall phosphorylates inhibitor protein
    phosphatase 2A essential mitosis. Science 2010, 330, 1670–1673.
Int. J. Mol. Sci. 2014, 15                                                                           2449

11. Smetana, J.H.; Zanchin, N  Interaction analysis heterotrimer formed phosphatase
    2A catalytic subunit, alpha 4 mammalian ortholog yeast Tip41 (TIPRL). FEBS J. 2007,
    274, 5891–5904.
12. Bernal, M.; Sanchez-Romero, M ; Salas-Pino, S.; Daga, R.R. Regulation fission yeast
    morphogenesis PP2A activator pta2. PLoS 2012, 7, e32823.
13. Mitchell, D ; Sprague, G.F., Jr. PhosphoTyrosyl Phosphatase Activator, Ncs1p (Rrd1p),
    functions Cla4p regulate G(2)/M transition Saccharomyces cerevisiae. Mol. Cell. Biol.
    2001, 21, 488–500.
14. Rempola, B.; Kaniak, ; Migdalski, ; Rytka, J.; Slonimski, P.P.; di Rago, J.P. Functional
    analysis RRD1 (YIL153w) RRD2 (YPL152w), encode putative activators     PhosphoTyrosyl Phosphatase Activity PP2A Saccharomyces cerevisiae. Mol. Gen. Genet.:
    MGG 2000, 262, 1081–1092.
15. Van Hoof, C.; Janssens, V.; Baere, ; Winde, J.H.; Winderickx, J.; Dumortier, F.;
    Thevelein, J.M.; Merlevede, W.; Goris, J. Saccharomyces cerevisiae homologue YPA1     mammalian PhosphoTyrosyl Phosphatase Activator protein phosphatase 2A controls
    progression G1 phase yeast cell cycle. J. Mol. Biol. 2000, 302, 103–120.
16. Van Hoof, C.; Janssens, V.; Baere, ; Stark, M.J.; Winde, J.H.; Winderickx, J.; Thevelein, J.M.;
    Merlevede, W.; Goris, J. Saccharomyces cerevisiae PhosphoTyrosyl Phosphatase Activator
    proteins required subset functions disrupted protein phosphatase 2A mutations.
    Exp. Cell Res. 2001, 264, 372–387.
17. Cayla, X.; van Hoof, C.; Bosch, M.; Waelkens, E.; Vandekerckhove, J.; Peeters, B.; Merlevede, W.;
    Goris, J. Molecular cloning, expression, characterization PTPA, protein activates     tyrosyl phosphatase activity protein phosphatase 2A. J. Biol. Chem. 1994, 269, 15668–15675.
18. Van Hoof, C.; Janssens, V.; Dinishiotu, ; Merlevede, W.; Goris, J. Functional analysis     conserved domains PhosphoTyrosyl Phosphatase Activator. Molecular cloning     homologues Drosophila melanogaster Saccharomyces cerevisiae. Biochemistry 1998,
    37, 12899–12908.
19. Jordens, J.; Janssens, V.; Longin, S.; Stevens, ; Martens, E.; Bultynck, G.; Engelborghs, Y.;
    Lescrinier, E.; Waelkens, E.; Goris, J.; et al. protein phosphatase 2A phosphatase activator     novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 2006, 281, 6349–6357.
20. Chao, Y.; Xing, Y.; Chen, Y.; Xu, Y.; Lin, ; Li, ; Jeffrey, P.D.; Stock, J.B.; Shi, Y. Structure
    mechanism PhosphoTyrosyl Phosphatase Activator. Mol. Cell 2006, 23, 535–546.
21. Leulliot, N.; Vicentini, G.; Jordens, J.; Quevillon-Cheruel, S.; Schiltz, M.; Barford, D.;
    van Tilbeurgh, H.; Goris, J. Crystal structure PP2A phosphatase activator: Implications     PP2A-specific PPIase activity. Mol. Cell 2006, 23, 413–424.
22. Magnusdottir, ; Stenmark, P.; Flodin, S.; Nyman, T.; Hammarstrom, M.; Ehn, M.; Bakali, H.M.;
    Berglund, H.; Nordlund, P. crystal structure human PP2A phosphatase activator reveals     novel fold highly conserved cleft implicated protein-protein interactions. J. Biol. Chem.
    2006, 281, 22434–22438.
23. Bhattacharyya, M.K.; Hong, ; Kongkasuriyachai, D.; Kumar, N. Plasmodium falciparum
    protein phosphatase type 1 functionally complements glc7 mutant Saccharomyces cerevisiae.
    Int. J. Parasitol. 2002, 32, 739–747.
Int. J. Mol. Sci. 2014, 15                                                                         2450

24. Blisnick, T.; Vincensini, L.; Fall, G.; Braun-Breton, C. Protein phosphatase 1,     Plasmodium falciparum essential enzyme, exported host cell implicated release
    infectious merozoites. Cell. Microbiol. 2006, 8, 591–601.
25. Dobson, S.; Kar, B.; Kumar, R.; Adams, B.; Barik, S. novel tetratricopeptide repeat (TPR)
    containing PP5 serine/threonine protein phosphatase malaria parasite, Plasmodium falciparum.
    BMC Microbiol. 2001, 1, 31.
26. Dobson, S.;  T.; Berriman, M.; del Vecchio, C.; Fairlamb, H.; Chakrabarti, D.; Barik, S.
    Characterization protein Ser/Thr phosphatases malaria parasite, Plasmodium falciparum:
    Inhibition parasitic calcineurin cyclophilin-cyclosporin complex. Mol. Biochem. Parasitol.
    1999, 99, 167–181.
27. Fernandez-Pol, S.; Slouka, ; Bhattacharjee, S.; Fedotova, Y.; Freed, S.;  X.; Holder, ;
    Campanella, E.; Low, P.S.; Mohandas, N.; et al. bacterial phosphatase-like enzyme     malaria parasite Plasmodium falciparum possesses tyrosine phosphatase activity implicated
    regulation band 3 dynamics parasite invasion. Eukaryot. Cell 2013, 12, 1179–1191.
28. Guttery, D.S.; Poulin, B.; Ferguson, D.J.; Szoor, B.; Wickstead, B.; Carroll, P.L.; Ramakrishnan, C.;
    Brady, D.; Patzewitz, E.M.; Straschil, U.; et al. unique protein phosphatase kelch-like
    domains (PPKL) Plasmodium modulates ookinete differentiation, motility invasion.
    PLoS Pathog. 2012, 8, e1002948.
29. Kumar, R.; Adams, B.; Oldenburg, ; Musiyenko, ; Barik, S. Characterisation expression
    PP1 serine/threonine protein phosphatase (PfPP1) malaria parasite,
    Plasmodium falciparum: Demonstration essential role using RNA interference. Malar. J.
    2002, 1, 5.
30. Kumar, R.; Musiyenko, ; Barik, S. Plasmodium falciparum calcineurin association     heat shock protein 90: Mechanisms antimalarial activity cyclosporin synergism
    geldanamycin. Mol. Biochem. Parasitol. 2005, 141, 29–37.
31. Kumar, R.; Musiyenko, ; Oldenburg, ; Adams, B.; Barik, S. Post-translational generation     constitutively active cores larger phosphatases malaria parasite, Plasmodium falciparum:
    Implications proteomics. BMC Mol. Biol. 2004, 5, 6.
32. Li, J.L.; Baker, D  Protein phosphatase beta, putative type-2A protein phosphatase     human malaria parasite Plasmodium falciparum. Eur. J. Biochem./FEBS 1997, 249, 98–106.
33. Li, J.L.; Baker, D  putative protein serine/threonine phosphatase Plasmodium falciparum
    contains large N-terminal extension unique inserts catalytic domain.
    Mol. Biochem. Parasitol. 1998, 95, 287–295.
34. Lindenthal, C.; Klinkert, M.Q. Identification biochemical characterisation protein
    phosphatase 5 homologue Plasmodium falciparum. Mol. Biochem. Parasitol. 2002, 120,
    257–268.
35. Mamoun, C.B.; Goldberg, D.E. Plasmodium protein phosphatase 2C dephosphorylates translation
    elongation factor 1beta inhibits PKC-mediated nucleotide exchange activity vitro.
    Mol. Microbiol. 2001, 39, 973–981.
36. Mamoun, C.B.; Sullivan, D.J., Jr.; Banerjee, R.; Goldberg, D.E. Identification     characterization unusual double serine/threonine protein phosphatase 2C malaria
    parasite Plasmodium falciparum. J. Biol. Chem. 1998, 273, 11241–11247.
Int. J. Mol. Sci. 2014, 15                                                                           2451

37. Patzewitz, E.M.; Guttery, D.S.; Poulin, B.; Ramakrishnan, C.; Ferguson, D.J.; Wall, R.J.; Brady, D.;
    Holder, ; Szoor, B.; Tewari, R. ancient protein phosphatase, SHLP1, critical microneme
    development Plasmodium ookinetes parasite transmission. Cell Rep. 2013, 3, 622–629.
38. Philip, N.; Vaikkinen, H.J.; Tetley, L.; Waters, P. unique Kelch domain phosphatase
    Plasmodium regulates ookinete morphology, motility invasion. PLoS 2012, 7,
    e44617.
39. Singh, S.;  K.R.; Chitnis, C.E. Role calcineurin actin dynamics regulated secretion
    microneme proteins Plasmodium falciparum merozoites erythrocyte invasion.
    Cell. Microbiol. 2013, doi:10.1111/cmi.12177.
40. Daher, W.; Browaeys, E.; Pierrot, C.; Jouin, H.; Dive, D.; Meurice, E.; Dissous, C.; Capron, M.;
    Tomavo, S.; Doerig, C.; et al. Regulation protein phosphatase type 1 cell cycle
    progression PfLRR1, novel leucine-rich repeat protein human malaria parasite
    Plasmodium falciparum. Mol. Microbiol. 2006, 60, 578–590.
41. Freville, ; Cailliau-Maggio, K.; Pierrot, C.; Tellier, G.; Kalamou, H.; Lafitte, S.; Martoriati, ;
    Pierce, R.J.; Bodart, J.F.; Khalife, J. Plasmodium falciparum encodes conserved active
    inhibitor-2 Protein Phosphatase type 1: Perspectives novel anti-plasmodial therapy.
    BMC Biol. 2013, 11, 80.
42. Freville, ; Landrieu, ; Garcia-Gimeno, M ; Vicogne, J.; Montbarbon, M.; Bertin, B.;
    Verger, ; Kalamou, H.; Sanz, P.; Werkmeister, E.; et al. Plasmodium falciparum inhibitor-3
    homolog increases protein phosphatase type 1 activity essential parasitic survival.
    J. Biol. Chem. 2012, 287, 1306–1321.
43. Dobson, S.; Kumar, R.; Bracchi-Ricard, V.; Freeman, S.; Al-Murrani, S.W.; Johnson, C.;
    Damuni, ; Chakrabarti, D.; Barik, S. Characterization unique aspartate-rich protein     SET/TAF-family human malaria parasite, Plasmodium falciparum, inhibits protein
    phosphatase 2A. Mol. Biochem. Parasitol. 2003, 126, 239–250.
44. Aurrecoechea, C.; Brestelli, J.; Brunk, B.P.; Dommer, J.; Fischer, S.; Gajria, B.; Gao, X.; Gingle, ;
    Grant, G.; Harb, O.S.; et al. PlasmoDB: functional genomic database malaria parasites.
    Nucleic Acids Res. 2009, 37, D539–D543.
45. Tamura, K.; Peterson, D.; Peterson, N.; Stecher, G.; Nei, M.; Kumar, S. MEGA5: Molecular
    evolutionary genetics analysis using maximum likelihood, evolutionary distance, maximum
    parsimony methods. Mol. Biol. Evol. 2011, 28, 2731–2739.
46. Pieper, U.; Webb, B.M.; Barkan, D.T.; Schneidman-Duhovny, D.; Schlessinger, ; Braberg, H.;
    Yang, ; Meng, E.C.; Pettersen, E.F.; Huang, C.C.; et al. ModBase, database annotated
    comparative protein structure models, associated resources. Nucleic Acids Res. 2011, 39,
    D465–D474.
47. Bowyer, P.W.; Simon, G.M.; Cravatt, B.F.; Bogyo, M. Global profiling proteolysis     rupture Plasmodium falciparum host erythrocyte. Mol. Cell. Proteomics 2011, 10,
    doi:10.1074/mcp.M110.001636.
48. Lopez-Barragan, M.J.; Lemieux, J.; Quinones, M.; Williamson, K.C.; Molina-Cruz, ; Cui, K.;
    Barillas-Mury, C.; Zhao, K.; Su, X  Directional gene expression antisense transcripts     sexual asexual stages Plasmodium falciparum. BMC Genomics 2011, 12, 587.
Int. J. Mol. Sci. 2014, 15                                                                           2452

49. Treeck, M.; Sanders, J.L.; Elias, J.E.; Boothroyd, J.C. phosphoproteomes     Plasmodium falciparum Toxoplasma gondii reveal unusual adaptations     parasites’ boundaries. Cell Host Microbe 2011, 10, 410–419.
50. Longin, S.; Jordens, J.; Martens, E.; Stevens, ; Janssens, V.; Rondelez, E.; Baere, ; Derua, R.;
    Waelkens, E.; Goris, J.; et al. inactive protein phosphatase 2A population associated     methylesterase activated PhosphoTyrosyl Phosphatase Activator. Biochem. J.
    2004, 380, 111–119.
51. Kuhn, Y.; Sanchez, C.P.; Ayoub, D.; Saridaki, T.; van Dorsselaer, ; Lanzer, M. Trafficking     phosphoprotein PfCRT digestive vacuolar membrane Plasmodium falciparum.
    Traffic 2010, 11, 236–249.
52. Lee, T.Y.; Lai, T.Y.; Lin, S.C.; Wu, C.W.; Ni, F.; Yang, Y.S.; Hung, L.Y.; Law, B.K.;
    Chiang, C.W. B56gamma3 regulatory subunit protein phosphatase 2A (PP2A) regulates S
    phase-specific nuclear accumulation PP2A G1 S transition. J. Biol. Chem. 2010, 285,
    21567–21580.
53. Van Hoof, C.; Martens, E.; Longin, S.; Jordens, J.; Stevens, ; Janssens, V.; Goris, J. Specific
    interactions PP2A PP2A-like phosphatases yeast PTPA homologues, Ypa1     Ypa2. Biochem. J. 2005, 386, 93–102.
54. Kinoshita, N.; Ohkura, H.; Yanagida, M. Distinct, essential roles type 1 2A protein
    phosphatases control fission yeast cell division cycle. Cell 1990, 63, 405–415.
55. Gotz, J.; Probst, ; Ehler, E.; Hemmings, B.; Kues, W. Delayed embryonic lethality mice
    lacking protein phosphatase 2A catalytic subunit Calpha. Proc. Natl. Acad. Sci. USA 1998, 95,
    12370–12375.
56. Yokoyama, D.; Saito-Ito, ; Asao, N.; Tanabe, K.; Yamamoto, M.; Matsumura, T. Modulation     growth Plasmodium falciparum vitro protein serine/threonine phosphatase inhibitors.
    Biochem. Biophys. Res. Commun. 1998, 247, 18–23.
57. Jeong, L.; Yang, Y. PP2A function mitotic kinases substrates cell cycle.
    BMB Rep. 2013, 46, 289–294.
58. Jiang, Y. Regulation cell cycle protein phosphatase 2A Saccharomyces cerevisiae.
    Microbiol. Mol. Biol. Rev. 2006, 70, 440–449.
59. Krasinska, L.; Domingo-Sananes, M.R.; Kapuy, O.; Parisis, N.; Harker, B.; Moorhead, G.;
    Rossignol, M.; Novak, B.; Fisher, D. Protein phosphatase 2A controls order dynamics     cell-cycle transitions. Mol. Cell 2011, 44, 437–450.
60. Lorca, T.; Bernis, C.; Vigneron, S.; Burgess, ; Brioudes, E.; Labbe, J.C.; Castro,  Constant
    regulation MPF amplification loop Greatwall-PP2A pathway required     metaphase II arrest correct entry embryonic cell cycle. J. Cell Sci. 2010, 123,
    2281–2291.
61. Ferrell, J.E., Jr. Xenopus oocyte maturation: New lessons good egg. BioEssays 1999, 21,
    833–842.
62. Trager, W.; Jensen, J.B. Human malaria parasites continuous culture. Science 1976, 193, 673–675